Literature DB >> 17917784

CT vs MRCP: optimal classification of IPMN type and extent.

Joshua A Waters1, C Max Schmidt, Jason W Pinchot, Patrick B White, Oscar W Cummings, Henry A Pitt, Kumar Sandrasegaran, Fatih Akisik, Thomas J Howard, Attila Nakeeb, Nicholas J Zyromski, Keith D Lillemoe.   

Abstract

INTRODUCTION: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are being diagnosed with increased frequency. CT scanning commonly serves as the primary imaging modality before surgery. We hypothesized MRCP provides better characterization of IPMN type/extent, which more closely matches actual pathology.
METHODS: Of 214 patients treated with IPMN (1991-2006), 30 had both preoperative CT and MRCP. Of these, 18 met imaging study criteria. Independent readers performed retrospective, blinded analyses using standardized criteria for IPMN type and extent.
RESULTS: A ductal connection was detected on 73% of MRCP scans and only 18% of CT. IPMN type was classified differently in seven (39%); four (22%) of which were read on CT as having main duct involvement where this was not appreciated on MRCP or found on surgical pathology. MRCP showed multifocal disease in 13(72%) versus only 9(50%) on CT. A different disease distribution was seen in 9(50%). Finally, 101 branch lesions were identified on MRCP compared to 46 on CT.
CONCLUSIONS: CT falls short of MRCP in detecting a ductal connection, estimating main duct involvement, and identification of small branch duct cysts. These factors influence diagnostic accuracy, cancer risk stratification and operative strategy. MRCP should be employed for optimal management of patients with IPMN.

Entities:  

Mesh:

Year:  2007        PMID: 17917784     DOI: 10.1007/s11605-007-0367-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

Review 1.  Secretin, 100 years later.

Authors:  William Y Chey; Ta-Min Chang
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

Review 2.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

3.  Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.

Authors:  Dushyant V Sahani; Rajagopal Kadavigere; Michael Blake; Carlos Fernandez-Del Castillo; Gregory Y Lauwers; Peter F Hahn
Journal:  Radiology       Date:  2006-02       Impact factor: 11.105

4.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

5.  HASTE MR cholangiopancreatography in the evaluation of intraductal papillary-mucinous tumors of the pancreas.

Authors:  Y Fukukura; F Fujiyoshi; M Sasaki; N Ichinari; H Inoue; Y Kajiya; M Nakajo
Journal:  J Comput Assist Tomogr       Date:  1999 Mar-Apr       Impact factor: 1.826

6.  Clinical management of intraductal papillary mucinous tumors of the pancreas based on imaging findings.

Authors:  T Wakabayashi; Y Kawaura; H Morimoto; K Watanabe; D Toya; Y Asada; Y Satomura; H Watanabe; T Okai; N Sawabu
Journal:  Pancreas       Date:  2001-05       Impact factor: 3.327

7.  Cystic pancreatic neoplasms: observe or operate.

Authors:  Kristine S Spinelli; Travis E Fromwiller; Roger A Daniel; James M Kiely; Attila Nakeeb; Richard A Komorowski; Stuart D Wilson; Henry A Pitt
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

8.  Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography.

Authors:  Hiroyuki Irie; Kengo Yoshimitsu; Hitoshi Aibe; Tsuyoshi Tajima; Akihiro Nishie; Tomohiro Nakayama; Daisuke Kakihara; Hiroshi Honda
Journal:  J Comput Assist Tomogr       Date:  2004 Jan-Feb       Impact factor: 1.826

9.  Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression.

Authors:  Walter M Klein; Ralph H Hruban; Andres J P Klein-Szanto; Robb E Wilentz
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  65 in total

Review 1.  Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis.

Authors:  Robert Grützmann; Stefan Post; Hans Detlev Saeger; Marco Niedergethmann
Journal:  Dtsch Arztebl Int       Date:  2011-11-18       Impact factor: 5.594

2.  Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle.

Authors:  Luca Barresi; Ilaria Tarantino; Antonino Granata; Gabriele Curcio; Mario Traina
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

3.  Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.

Authors:  Dae Wook Hwang; Jin-Young Jang; Seung Eun Lee; Chang-Sup Lim; Kuhn Uk Lee; Sun-Whe Kim
Journal:  Langenbecks Arch Surg       Date:  2010-07-18       Impact factor: 3.445

Review 4.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 5.  [Surgical therapy of intraductal papillary mucinous neoplasms of the pancreas].

Authors:  S Fritz; M W Büchler; J Werner
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

6.  [Organ- and function-preserving pancreatic surgery].

Authors:  M W Büchler; M N Wente
Journal:  Chirurg       Date:  2009-01       Impact factor: 0.955

7.  Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience.

Authors:  L Calculli; R Pezzilli; C Brindisi; R Morabito; R Casadei; M Zompatori
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

Review 8.  Radiological Workup of Cystic Neoplasms of the Pancreas.

Authors:  Thomas L Bollen; Frank J Wessels
Journal:  Visc Med       Date:  2018-06-15

9.  Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.

Authors:  Stefano Crippa; Carlos Fernández-Del Castillo; Roberto Salvia; Dianne Finkelstein; Claudio Bassi; Ismael Domínguez; Alona Muzikansky; Sarah P Thayer; Massimo Falconi; Mari Mino-Kenudson; Paola Capelli; Gregory Y Lauwers; Stefano Partelli; Paolo Pederzoli; Andrew L Warshaw
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-14       Impact factor: 11.382

Review 10.  Management of mucin-producing cystic neoplasms of the pancreas.

Authors:  Stefan Fritz; Andrew L Warshaw; Sarah P Thayer
Journal:  Oncologist       Date:  2009-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.